Search for a trainee based upon last name or email address:
First Name: Daniel
Last Name: Parker
Email: daniel.parker@duke.edu
Site Number/Institution: Duke University School of Medicine
Reason: * Lilly Rater Academy
Lilly Specific Study (if applicable): J5K-MC-OQAA
Application Date: September 5, 2025 at 7:44 am
First Name: Pedro
Last Name: Ruschel
Email: neurohallruschel@gmail.com
Site Number/Institution: NPCRS
Reason: Other Trial Not Listed Above
Lilly Specific Study (if applicable):
Application Date: September 5, 2025 at 6:12 am
First Name: Nao
Last Name: Yamamoto
Email: funabiki.nao@gmail.com
Site Number/Institution: Okayama City General Medical Center
Reason: Other Trial Not Listed Above
Lilly Specific Study (if applicable):
Application Date: September 5, 2025 at 1:55 am
First Name: Yuki
Last Name: Kino
Email: totoyuki@hotmail.com
Site Number/Institution: Yuki
Reason: Clinical Care Purposes
Lilly Specific Study (if applicable):
Application Date: September 5, 2025 at 1:55 am
First Name: Matthew
Last Name: Thomas
Email: mattythomas167@gmail.com
Site Number/Institution: Queen Elizabeth Hospital
Reason: Clinical Care Purposes
Lilly Specific Study (if applicable):
Application Date: September 5, 2025 at 12:54 am
First Name: Zeynel
Last Name: Alaca
Email: zeynell.alaca@gmail.com
Site Number/Institution: Cogstate
Reason: Clinical Care Purposes
Lilly Specific Study (if applicable):
Application Date: September 4, 2025 at 7:53 pm
First Name: Matthew
Last Name: Bennett
Email: m.bennett25@imperial.ac.uk
Site Number/Institution: Imperial College London
Reason: Personal Interest or Professional Development
Lilly Specific Study (if applicable):
Application Date: September 4, 2025 at 5:09 pm
First Name: Tasha
Last Name: Suarez
Email: tsuarez@ergclinical.com
Site Number/Institution: Brain Matters Research
Reason: Cogstate Rater Academy
Lilly Specific Study (if applicable):
Application Date: September 4, 2025 at 3:08 pm
First Name: MaryBeth
Last Name: Bailar
Email: mbailar@cogstate.com
Site Number/Institution: Cogstate
Reason: * A3/A45 Study: Protocol BAN2401-G000-303
Lilly Specific Study (if applicable):
Application Date: September 4, 2025 at 3:02 pm
First Name: Karin
Last Name: Deleon
Email: kdeleon@velocityclinicalresearch.com
Site Number/Institution: Velocity Clinical Research
Reason: Clinical Care Purposes
Lilly Specific Study (if applicable):
Application Date: September 4, 2025 at 1:16 pm